Design and interpretation of clinical trials of long-acting analgesics
Neidert, G.L.
PharmacoTherapy 2(5): 285-286
1982
ISSN/ISBN: 0277-0008 PMID: 6763209 Document Number: 186996
Document emailed within 1 workday
Related Documents
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Lee, Y.J.; Wesley, R.A. 1981: Statistical contributions to phase Ii trials in cancer: interpretation, analysis and design Seminars in Oncology 8(4): 403-416
Liao, P.-A.; Pan, S.-W.; Chen, C.-Y.; Deng, C.-Y.; Dong, Y.-H. 2023: Prescription Patterns of new use of Fixed-Dose Combination Inhalers in Patients with Chronic Obstructive Pulmonary Disease: Long-Acting β2 Agonists Plus Long-Acting Muscarinic Antagonists versus Long-Acting β2 Agonists Plus Inhaled Corticosteroids International Journal of Chronic Obstructive Pulmonary Disease 18: 553-563
Yokono, K. 2001: Recent trends of development of rapid-acting and long-acting human insulin analogues--its biological characteristics and clinical availability Nihon Rinsho. Japanese Journal of Clinical Medicine 59(11): 2127-2133
Kishimoto, T. 2016: Studying the Efficacy of Long-acting Injectable Antipsychotics (LAI) While Considering Study Design Limitations : A Discussion in Favor of LAI Seishin Shinkeigaku Zasshi 118(8): 607-614
Gallo, M.F.; Warner, L.; Jamieson, D.J.; Steiner, M.J. 2011: Do women using long-acting reversible contraception reduce condom use? a novel study design incorporating semen biomarkers Infectious Diseases in Obstetrics and Gynecology 2011: 107140
López-Jiménez, F.; Paniagua, D.; Lamas, G.A. 1998: Interpretation of negative clinical trials Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 50(5): 435-440
Inagaki, A. 2016: Safety of Long-acting Injectable Antipsychotics Is Long-acting Injection a High-risk Treatment Option? Seishin Shinkeigaku Zasshi 118(8): 589-597
Carneiro, Aónio.Vaz. 2003: Measures of association in clinical trials: definition and interpretation Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 22(11): 1393-1401
Belsey, E.M. 1991: Menstrual bleeding patterns in untreated women and with long-acting methods of contraception. Task Force on Long-Acting Systemic Agents for Fertility Regulation Advances in contraception: the official journal of the Society for the Advancement of Contraception 7(2-3): 257-270
Belsey, E.M. 1991: Menstrual bleeding patterns in untreated women and with long-acting methods of contraception. Task Force on Long-Acting Systemic Agents for Fertility Regulation Advances in contraception: the official journal of the Society for the Advancement of Contraception 7(2-3): 257-270
Overall, J.E. 1989: Design issues in clinical trials Progress in Clinical and Biological Research 317: 1291-1299
Prasad, V.K. 2019: Improving the design of pivotal clinical trials Clinical Advances in Hematology and Oncology: H&o 17(3): 150-152
Antczak-Bouckoms, A.; Chalmers, T.C. 1988: The importance of design and analysis in clinical trials Journal of Oral Implantology 14(1): 36-42
Gehan, E.A. 1982: Design of controlled clinical trials: use of historical controls Cancer Treatment Reports 66(5): 1089-1093
Lusher, J.M. 1984: Assessment of response to treatment and design of clinical trials Progress in Clinical and Biological Research 150: 167-179
Kamp, H.D. 1986: Central-acting analgesics Zahnarztliche Praxis 37(6): 222-225
Dellinger, E.P. 1991: Design and evaluation of clinical trials of antimicrobial agents in surgery Surgery Gynecology and Obstetrics 172 Suppl: 65-72
Fleming, T.R. 1999: Issues in the design of clinical trials: insights from the trastuzumab (Herceptin) experience Seminars in Oncology 26(4 Suppl. 12): 102-107